Pharmacology: The latest animal-specific macrolide semi-synthetic antibiotic, it is a derivative of tylosin. Tildipirosin is a broad-spectrum antibacterial drug with antibacterial activity against some gram-positive and gram-negative bacteria, especially sensitive to pathogenic bacteria that cause respiratory diseases in pigs and cattle, such as Actinobacillus pleuropneumoniae, Pasteurella, Bordetella bronchiseptica, Haemophilus parasuis, Hemolytic Mannheim, etc.
Indication: Mainly used for the treatment of bacterial infectious respiratory diseases in cattle and pigs.
Dosage: Based on Tildipirosin, 4 mg/kg, the whole course of treatment is only used once. For cattle, subcutaneous injection, the single point injection should not exceed 10ml; For pig, intramuscular injection, the single point injection should not exceed 5ml.


| Technical Specifications | |||
|---|---|---|---|
| Specification | EP; USP | Usage | Antibiotic |
| Raw Material | Tildipirosin | Species | Cattle, sheep, swine, camels |
| Packing | 25kg/drum | Delivery | 3-10 days |
| MOQ | 25kg | Payment | T/T, D/P, D/A, L/C |




Established in 2002, our company is a large GMP-certified veterinary drug enterprise, with R&D, production and sales of veterinary APIs, preparations, premixed feeds and feed additives. We have established an innovative R&D system and are a technologically advanced veterinary enterprise.
We provide APIs, more than 100 own-label preparations, and OEM & ODM service. We have built complete quality management systems including ISO9001, GMP, and have passed international inspections. We export to over 60 countries and regions worldwide.


